Skip to main content

#Coronavirus Disease Research #References (by AMEDEO, Feb. 23 '25)

Image
By G.M.


 

    Antiviral Res

  1. INOUE A, Ichikawa T, Wada D, Maruyama S, et al
    M49L and other drug resistance mutations emerging in individuals after administration of ensitrelvir in Japanese clinical settings.
    Antiviral Res. 2025;236:106118.
    PubMed         Abstract available

  2. ZIAN D, Iaconis D, Nenci S, Crusco A, et al
    The Efficiency of High-Throughput Screening (HTS) and in-silico data analysis during medical emergencies: identification of effective antiviral 3CLpro inhibitors.
    Antiviral Res. 2025 Feb 18:106119. doi: 10.1016/j.antiviral.2025.106119.
    PubMed         Abstract available


    Clin Infect Dis

  3. LUETKEMEYER AF, Chew KW, Lacey S, Hughes MD, et al
    Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial.
    Clin Infect Dis. 2025 Feb 17:ciaf029. doi: 10.1093.
    PubMed         Abstract available

  4. SIM BZ, Wolfe CR
    Antiviral Trials-Navigating the Shifting Sands of a Pandemic.
    Clin Infect Dis. 2025 Feb 17:ciaf031. doi: 10.1093.
    PubMed        


    Emerg Infect Dis

  5. FERREIRA FC, Pervin T, Tang WW, Hediger JA, et al
    Respiratory Shedding of Infectious SARS-CoV-2 Omicron XBB.1.41.1 Lineage among Captive White-Tailed Deer, Texas, USA.
    Emerg Infect Dis. 2025;31:267-274.
    PubMed         Abstract available

  6. DAVIES MA, de Gier B, Guy RL, Coelho J, et al
    Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England.
    Emerg Infect Dis. 2025;31:229-236.
    PubMed         Abstract available


    Graefes Arch Clin Exp Ophthalmol

  7. SUN M, Wu M, Zhang L, Zhou H, et al
    Clinical characteristics of optic neuritis following COVID-19 during Omicron outbreak in China.
    Graefes Arch Clin Exp Ophthalmol. 2025 Feb 21. doi: 10.1007/s00417-025-06780.
    PubMed         Abstract available


    Intensive Care Med

  8. OLMOS M, Fuentes N, Busico M, Gallardo A, et al
    Effectiveness of bundle of care on tolerance of awake-prone positioning in patients with acute respiratory failure. A multicenter observational study.
    Intensive Care Med. 2025 Feb 17. doi: 10.1007/s00134-025-07804.
    PubMed         Abstract available


    J Infect

  9. AO G, Li T, Wang Y, Balzer N, et al
    The effect of amubarvimab-romlusevimab on clinical outcomes in patients with COVID-19: A meta-analysis.
    J Infect. 2025;90:106442.
    PubMed        

  10. MAZARAKIS N, Toh ZQ, Neal E, Bright K, et al
    The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose.
    J Infect. 2025 Feb 18:106447. doi: 10.1016/j.jinf.2025.106447.
    PubMed         Abstract available


    J Med Virol

  11. ZHANG Y, Chen H, Li Y, Luo C, et al
    Animal Models for Long COVID: Current Advances, Limitations, and Future Directions.
    J Med Virol. 2025;97:e70237.
    PubMed         Abstract available

  12. LI Y, Lu J, He L, Jiang C, et al
    Repeated Omicron Infections Overcome T Cell Immune Imprinting to Original SARS-CoV-2.
    J Med Virol. 2025;97:e70264.
    PubMed         Abstract available

  13. FRAENKEL CJ, Thuresson S, Medstrand P, Alsved M, et al
    Comparison of Airborne SARS-CoV-2 Omicron and Pre-Delta Variants Around Infected Patients.
    J Med Virol. 2025;97:e70258.
    PubMed         Abstract available

  14. KIM J, Han E, Kim J, Kim YJ, et al
    Comparative Evaluation of the PowerChek Respiratory Virus Panel RT-PCR Assay Detecting 16 Respiratory Viruses Including SARS-CoV-2.
    J Med Virol. 2025;97:e70243.
    PubMed         Abstract available

  15. ZHAO Y, He C, Peng M, Li M, et al
    Large-Scale Screening of CD4(+) T-Cell Epitopes From SARS-CoV-2 Proteins and the Universal Detection of SARS-CoV-2 Specific T Cells for Northeast Asian Population.
    J Med Virol. 2025;97:e70241.
    PubMed         Abstract available

  16. HO SY, Zhou YT, Ho SY, Hu YL, et al
    Clinical Characteristics and Severity Predictors of Pediatric Adenovirus Infections.
    J Med Virol. 2025;97:e70248.
    PubMed         Abstract available

  17. HOTA M, Wondeu ALD, Abakar MF, Dezoumbe K, et al
    Integrated Seroprevalence and Genome-Based Study of SARS-CoV-2 Viral Strains in N'Djamena: Insights Into Chad's COVID-19 Epicenter.
    J Med Virol. 2025;97:e70234.
    PubMed         Abstract available

  18. DAMODAR T, Pattabiraman C, Singh B, Jose M, et al
    Microbiological Investigations for Chikungunya Virus in Children With Acute Encephalitis Syndrome in a Non-Outbreak Setting in Southern India.
    J Med Virol. 2025;97:e70233.
    PubMed         Abstract available


    J Virol

  19. SOULTSIOTI M, de Jong AWM, Blomberg N, Tas A, et al
    Perturbation of de novo lipogenesis hinders MERS-CoV assembly and release, but not the biogenesis of viral replication organelles.
    J Virol. 2025 Feb 20:e0228224. doi: 10.1128/jvi.02282.
    PubMed         Abstract available


    Lancet Infect Dis

  20. KRAMMER F, Barclay WS, Beer M, Brown IH, et al
    Europe needs a sustainably funded influenza research and response network.
    Lancet Infect Dis. 2025 Feb 17:S1473-3099(25)00068.
    PubMed        


    N Engl J Med

  21. BROWN JR, Seymour JF, Jurczak W, Aw A, et al
    Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
    N Engl J Med. 2025;392:748-762.
    PubMed         Abstract available


    Nature

  22. MARR LC
    Researchers overlooked airborne diseases for centuries - then COVID-19 changed everything.
    Nature. 2025;638:607-608.
    PubMed        


  23. Learn COVID pandemic lessons - before it's too late.
    Nature. 2025 Feb 18. doi: 10.1038/d41586-025-00498.
    PubMed        

  24. MALLAPATY S
    What sparked the COVID pandemic? Mounting evidence points to raccoon dogs.
    Nature. 2025 Feb 21. doi: 10.1038/d41586-025-00426.
    PubMed        


    Radiology

  25. NARAYAN AK, Foster N, Kadom N, Scott JA, et al
    Six Steps to Improving Health Equity Using Quality Improvement and Patient Safety Tools.
    Radiology. 2025;314:e232750.
    PubMed         Abstract available


    Science

  26. ZASLAVSKY ME, Craig E, Michuda JK, Sehgal N, et al
    Disease diagnostics using machine learning of B cell and T cell receptor sequences.
    Science. 2025;387:eadp2407.
    PubMed         Abstract available


    Travel Med Infect Dis

  27. FLOREZ L, Echeverri-De la Hoz D, Calderon A, Serrano-Coll H, et al
    Preclinical evaluation of the RBD-Trimeric vaccine: A novel approach to strengthening biotechnological sovereignty in developing countries against SARS-CoV-2 variants.
    Travel Med Infect Dis. 2025;64:102820.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »